glp 1 receptor agonist diabetes Trends in the Development of GLP-1 Agonists GLP-1 receptor agonists (GLP-1RAs): cardiovascular
Description
Common areas reported by those on weight loss programs include the upper arms, the back, the shoulders, and the thighs
It is injected subcutaneously in the abdomen, thigh, or upper arm
Beyond the indirect benefits of weight loss on inflammation, research is also examining whether GLP-1 medications directly affect other inflammatory processes
The key word in the safety data is "no increase in serious cardiovascular events." That said, the absence of evidence is not evidence of absence
Mao D, Cao H, Shi M, Wang CC, Kwong J, Li JJX, et al
